Table 2.
Pathological Condition | Effect | Target Tissue/Organ | Reference |
---|---|---|---|
Atherosclerosis | ↓ LDL oxidation, foam cell formation | Arteries | [24] |
Non-fatal MI, CV death | ↓ stenosis, ↓ atherosclerosis | Arteries, heart | [26,27] |
Coronary artery disease | ↓ stenosis, ↓ coronary artery lesions | Arteries | [28] |
Non-fatal MI | ↓ atherosclerotic lesion formation | Arteries | [29] |
Arterial dysfunction | ↓ LDL oxidation, × PKC | Arteries, endothelium | [30] |
Secondary non-fatal MI, CV death (from chronic hemodialysis) | ↓ LDL oxidation, ↓ atherosclerotic plaque, ↓ platelet aggregation, ↓ ischemic stroke |
Vascular system | [31] |
Endothelial dysfunction, MI, CVD | × antagonistic effect on Hp2-2 genotypes | Vascular system | [33] |
↓: reduces rate of; ×: suppresses; LDL: low-density lipoprotein; MI: myocardial infarction; CV: cardiovascular; PKC: protein kinase C.